Activist 13D/13G Filings - Aisling Capital IV LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-12
4:26 pm
Purchase
13GElevation Oncology Inc.
ELEV
Aisling Capital IV LP2,913,005
4.920%
34,709increase
(+1.21%)
View
2024-02-06
4:15 pm
Purchase
13GElevation Oncology Inc.
ELEV
Aisling Capital IV LP2,878,296
6.800%
1,735increase
(+0.06%)
View
2023-03-03
4:30 pm
Purchase
13DMARKER THERAPEUTICS INC
MRKR
Aisling Capital IV LP464,285
5.460%
464,285increase
(New Position)
View
2023-02-08
5:00 pm
Purchase
13GElevation Oncology Inc.
ELEV
Aisling Capital IV LP2,876,561
12.340%
10,413increase
(+0.36%)
View
2022-02-14
12:16 pm
Purchase
13GElevation Oncology Inc.
ELEV
Aisling Capital IV LP2,866,148
12.330%
2,866,148increase
(New Position)
View
2022-02-14
12:14 pm
Purchase
13GViracta Therapeutics Inc.
VIRX
Aisling Capital IV LP288,571
0.770%
288,571increase
(New Position)
View